Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00393848Phase 2Completed
Phase 2, randomised, double-blind trial of ketoconazole and essential amino acids-University of Oregon in muscle atrophy, sponsored by University of Arkansas. Started Oct 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00393848.